Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-24-033955
Filing Date
2024-11-07
Accepted
2024-11-07 16:40:50
Documents
81
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q pbyi20240930_10q.htm   iXBRL 10-Q 1484006
2 EXHIBIT 31.1 ex_722429.htm EX-31.1 8324
3 EXHIBIT 31.2 ex_722430.htm EX-31.2 8349
4 EXHIBIT 32.1 ex_722431.htm EX-32.1 5100
5 EXHIBIT 32.2 ex_722432.htm EX-32.2 5118
  Complete submission text file 0001437749-24-033955.txt   7879683

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA pbyi-20240930.xsd EX-101.SCH 69797
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pbyi-20240930_cal.xml EX-101.CAL 63881
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pbyi-20240930_def.xml EX-101.DEF 442116
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE pbyi-20240930_lab.xml EX-101.LAB 421429
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pbyi-20240930_pre.xml EX-101.PRE 480817
84 EXTRACTED XBRL INSTANCE DOCUMENT pbyi20240930_10q_htm.xml XML 1344947
Mailing Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024
Business Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024 (424) 248-6500
PUMA BIOTECHNOLOGY, INC. (Filer) CIK: 0001401667 (see all company filings)

EIN.: 770683487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35703 | Film No.: 241436619
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)